New £50m venture capital fund will give a shot in the arm to UK life sciences

A brand new £50m venture capital fund launches today with a plan to invest in the UK's flourishing life sciences sector.

Scotland’s TCB inks CAR-T deal with Japan’s NIPRO

Scotland’s TC Biopharm (TCB) has secured a major investment from Japan with a deal centered on developing a novel gamma-delta CAR-T therapy to treat cancer, as well as a grant from Scottish Enterprise worth £2.7 million to fund preclinical activities.

Acerus Enters into a Licensing Agreement with Viramal to Commercialize the Elegant™ Franchise in Canada

Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has entered into a license, development and supply agreement with Viramal Limited (“Viramal”), a London-based specialty pharmaceutical company developing therapeutics that improve the quality of women’s health, granting Acerus the exclusive rights to commercialize the Elegant™ franchise in Canada.

bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy

– Deal combines TC BioPharm’s leading gamma delta T Cell capabilities with bluebird’s proven expertise in all stages of CAR T and gene therapy product development to discover and develop …

Age of Discovery (PharmaTimes, November 2017)

Five years on from Pfizer selling Discovery Park, the site's current chief executive Toby Hunter tells PharmaTimes about the plans for its future.

NCL Innovation Leads Second Round of investment in Coomtech Ltd

NCL Innovation, the UK’s leading early stage technology investor, has joined a second financing round for Kent based start-up Coomtech Ltd. The investment was made via the NCL’s Discovery Park Technology Investment Fund (DPTIF).

FutureNova FlipPad – Media Coverage in March 2017

Following the news of the first US sales of FutureNova Ltd’s FlipPad® sterile iPad® case, the product has been receiving positive press coverage in a number of outlets: Medical Plastic …

NCL Innovation leads equity investment round into ‘game-changing’ technology destined to save thousands of lives through real time detection of airborne asbestos

NCL Innovation, the UK’s leading early stage technology investor, is leading a funding round for start-up Alert Technology, helping the innovative company to take its life saving technology from concept through to commercial success.

Kent based sterile technology company FutureNova enjoys international success with first US sales with plans to scale up manufacturing to meet market demand from the health sector

FutureNova Ltd, backed by the Kent County Council run EXEK equity fund, has made its first successful sales in the United States with plans for a rapid scale up of its Kent based production process following a take-off in overseas demand for its FlipPad® sterile iPad® case.

Discovery Park Technology Fund invests in pioneering clinical development company, TC BioPharm (TCB) providing a launchpad for clinical trials of new treatments for cancer and viral infections

In February 2016, the technology fund run by NCL Innovation, UK’s leading early stage technology investor, announced its support of TC BioPharm (TCB), directly investing seed-finance of £500k from a …